Physical frailty and sarcopenia are two common and largely overlapping geriatric conditions upstream of the disabling cascade. The lack of a unique operational definition for physical frailty and sarcopenia and the complex underlying pathophysiology make the development of biomarkers for these conditions extremely challenging. Indeed, the current definitional ambiguities of physical frailty and sarcopenia, together with their heterogeneous clinical manifestations, impact the accuracy, specificity, and sensitivity of individual biomarkers proposed so far. In this review, the current state of the art in the development of biomarkers for physical frailty and sarcopenia is presented. A novel approach for biomarker identification and validation is also introduced that moves from the ‘one fits all’ paradigm to a multivariate methodology.

Calvani, R., Marini, F., Cesari, M., Tosato, M., Anker, S. D., Von Haehling, S., Miller, R. R., Bernabei, R., Landi, F., Marzetti, E., Biomarkers for physical frailty and sarcopenia: State of the science and future developments, <<JOURNAL OF CACHEXIA, SARCOPENIA AND MUSCLE>>, 2015; 6 (4): 278-286. [doi:10.1002/jcsm.12051] [http://hdl.handle.net/10807/171752]

Biomarkers for physical frailty and sarcopenia: State of the science and future developments

Calvani, Riccardo;Cesari, Matteo;Bernabei, Roberto;Landi, Francesco;Marzetti, Emanuele
2015

Abstract

Physical frailty and sarcopenia are two common and largely overlapping geriatric conditions upstream of the disabling cascade. The lack of a unique operational definition for physical frailty and sarcopenia and the complex underlying pathophysiology make the development of biomarkers for these conditions extremely challenging. Indeed, the current definitional ambiguities of physical frailty and sarcopenia, together with their heterogeneous clinical manifestations, impact the accuracy, specificity, and sensitivity of individual biomarkers proposed so far. In this review, the current state of the art in the development of biomarkers for physical frailty and sarcopenia is presented. A novel approach for biomarker identification and validation is also introduced that moves from the ‘one fits all’ paradigm to a multivariate methodology.
2015
Inglese
Calvani, R., Marini, F., Cesari, M., Tosato, M., Anker, S. D., Von Haehling, S., Miller, R. R., Bernabei, R., Landi, F., Marzetti, E., Biomarkers for physical frailty and sarcopenia: State of the science and future developments, <<JOURNAL OF CACHEXIA, SARCOPENIA AND MUSCLE>>, 2015; 6 (4): 278-286. [doi:10.1002/jcsm.12051] [http://hdl.handle.net/10807/171752]
File in questo prodotto:
File Dimensione Formato  
171752.pdf

accesso aperto

Tipologia file ?: Versione Editoriale (PDF)
Licenza: Creative commons
Dimensione 550.24 kB
Formato Unknown
550.24 kB Unknown Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10807/171752
Citazioni
  • ???jsp.display-item.citation.pmc??? 79
  • Scopus 203
  • ???jsp.display-item.citation.isi??? 184
social impact